Advertisement
Screener

PETMED EXPRESS, INC. (PETS) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

1.8 / 5 stars · 20/56 Roast Me

PETMED EXPRESS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

PETMED EXPRESS, INC. (PETS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 127.00 thousand shares for the 12-month period ending 2023-03-31, per its 10-K/A filed 2024-04-15.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2024-04-15

  • PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2020-06-30 was 0.00 shares.
  • PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2023 was 127.00K shares, a 82.36% decline from fiscal 2022.
  • PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2022 was 720.00K shares, a 579.25% increase from fiscal 2021.
  • PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2021 was 106.00K shares, a 7.83% decline from fiscal 2020.
  • PETMED EXPRESS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2020 was 115.00K shares, a 35.29% increase from fiscal 2019.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month
2023-03-31127.00K shares
10-K/A · filed 2024-04-15
2022-03-31720.00K shares
10-K · filed 2022-05-24
2021-03-31106.00K shares
10-K · filed 2021-05-25
2020-06-300.00 shares
10-Q · filed 2020-08-03
2020-03-31115.00K shares
10-K · filed 2020-05-26
2019-03-3185.00K shares
10-K · filed 2019-05-28
2018-03-3179.00 shares
10-K · filed 2018-05-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVS HEALTH Corp (CVS)United States$108.783B27.06